Literature DB >> 34478015

The Effect of PrEP Use Disclosure on Adherence in a Cohort of Adolescent Girls and Young Women in South Africa.

Danielle Giovenco1,2, Audrey Pettifor3, Kimberly A Powers3, Lisa Hightow-Weidman4, Brian W Pence3, Jessie K Edwards3, Katherine Gill5, Jennifer F Morton6, Ariane van der Straten7,8, Connie Celum6,9, Linda-Gail Bekker5.   

Abstract

Effective strategies to support PrEP adherence among adolescent girls and young women (AGYW) are needed. We examined PrEP use disclosure and its effect on adherence among 200 AGYW ages 16-25 initiating PrEP in South Africa to help inform these  strategies. We estimated the relative prevalence of high adherence (intracellular tenofovir-diphosphate concentration ≥ 700 fmol/punch) 3- and 6-months after PrEP initiation among those who disclosed vs. did not disclose their PrEP use, both overall and by age. Most AGYW disclosed to a parent (58%), partner (58%), or friend (81%) by month 6. We did not observe a strong effect of disclosure on adherence overall; however, among younger AGYW (≤ 18 years), those who disclosed to a parent were 6.8 times as likely to have high adherence at month 6 than those who did not (95% CI 1.02, 45.56). More work is needed to understand parents' roles as allies and identify ways peers and partners can motivate PrEP use for AGYW.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Adolescent girls and young women; Disclosure; HIV prevention; PrEP; Pre-exposure prophylaxis

Mesh:

Substances:

Year:  2021        PMID: 34478015      PMCID: PMC8891396          DOI: 10.1007/s10461-021-03455-x

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  33 in total

1.  A modified poisson regression approach to prospective studies with binary data.

Authors:  Guangyong Zou
Journal:  Am J Epidemiol       Date:  2004-04-01       Impact factor: 4.897

2.  Adolescence and the social determinants of health.

Authors:  Russell M Viner; Elizabeth M Ozer; Simon Denny; Michael Marmot; Michael Resnick; Adesegun Fatusi; Candace Currie
Journal:  Lancet       Date:  2012-04-25       Impact factor: 79.321

3.  Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots following Directly Observed Therapy.

Authors:  Peter L Anderson; Albert Y Liu; Jose R Castillo-Mancilla; Edward M Gardner; Sharon M Seifert; Cricket McHugh; Theresa Wagner; Kayla Campbell; Mary Morrow; Mustafa Ibrahim; Susan Buchbinder; Lane R Bushman; Jennifer J Kiser; Samantha MaWhinney
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

4.  Disclosure of PrEP use by young women in South Africa and Tanzania: qualitative findings from a demonstration project.

Authors:  Fiona Scorgie; Nomhle Khoza; Deborah Baron; Shelley Lees; Sheila Harvey; Lethabo Ramskin; Anne Stangl; Manuela Colombini; Emma Mashauri; Sinead Delany-Moretlwe
Journal:  Cult Health Sex       Date:  2020-03-04

5.  Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study.

Authors:  Jean-Michel Molina; Isabelle Charreau; Bruno Spire; Laurent Cotte; Julie Chas; Catherine Capitant; Cecile Tremblay; Daniela Rojas-Castro; Eric Cua; Armelle Pasquet; Camille Bernaud; Claire Pintado; Constance Delaugerre; Luis Sagaon-Teyssier; Soizic Le Mestre; Christian Chidiac; Gilles Pialoux; Diane Ponscarme; Julien Fonsart; David Thompson; Mark A Wainberg; Veronique Doré; Laurence Meyer
Journal:  Lancet HIV       Date:  2017-07-23       Impact factor: 12.767

6.  Degrees of disclosure: a study of women's covert use of the diaphragm in an HIV prevention trial in sub-Saharan Africa.

Authors:  Nuriye Nalan Sahin-Hodoglugil; Ariane van der Straten; Helen Cheng; Elizabeth T Montgomery; Deborah Kacanek; Sibongile Mtetwa; Neetha Morar; Jane Munyoro; Nancy Padian
Journal:  Soc Sci Med       Date:  2009-09-16       Impact factor: 4.634

Review 7.  Our future: a Lancet commission on adolescent health and wellbeing.

Authors:  George C Patton; Susan M Sawyer; John S Santelli; David A Ross; Rima Afifi; Nicholas B Allen; Monika Arora; Peter Azzopardi; Wendy Baldwin; Christopher Bonell; Ritsuko Kakuma; Elissa Kennedy; Jaqueline Mahon; Terry McGovern; Ali H Mokdad; Vikram Patel; Suzanne Petroni; Nicola Reavley; Kikelomo Taiwo; Jane Waldfogel; Dakshitha Wickremarathne; Carmen Barroso; Zulfiqar Bhutta; Adesegun O Fatusi; Amitabh Mattoo; Judith Diers; Jing Fang; Jane Ferguson; Frederick Ssewamala; Russell M Viner
Journal:  Lancet       Date:  2016-05-09       Impact factor: 79.321

8.  PrEP as a Lifestyle and Investment for Adolescent Girls and Young Women in Sub-Saharan Africa.

Authors:  Jessica E Haberer; Nelly Mugo; Jared M Baeten; Maria Pyra; Elizabeth Bukusi; Linda-Gail Bekker
Journal:  J Int Assoc Provid AIDS Care       Date:  2019 Jan-Dec

9.  PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized controlled trial.

Authors:  Connie Celum; Sybil Hosek; Mandisa Tsholwana; Sheetal Kassim; Shorai Mukaka; Bonnie J Dye; Subash Pathak; Nyaradzo Mgodi; Linda-Gail Bekker; Deborah J Donnell; Ethan Wilson; Krista Yuha; Peter L Anderson; Yaw Agyei; Heather Noble; Scott M Rose; Jared M Baeten; Jessica M Fogel; Adeola Adeyeye; Lubbe Wiesner; James Rooney; Sinead Delany-Moretlwe
Journal:  PLoS Med       Date:  2021-06-18       Impact factor: 11.069

10.  Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.

Authors:  Sheena McCormack; David T Dunn; Monica Desai; David I Dolling; Mitzy Gafos; Richard Gilson; Ann K Sullivan; Amanda Clarke; Iain Reeves; Gabriel Schembri; Nicola Mackie; Christine Bowman; Charles J Lacey; Vanessa Apea; Michael Brady; Julie Fox; Stephen Taylor; Simone Antonucci; Saye H Khoo; James Rooney; Anthony Nardone; Martin Fisher; Alan McOwan; Andrew N Phillips; Anne M Johnson; Brian Gazzard; Owen N Gill
Journal:  Lancet       Date:  2015-09-09       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.